Search research articles
Contact Us
Filters
Showing results (151-160 of 265) with videos related to
Page
of 27
Sort By:
The Journal of International Medical Research
|
February 2, 2022
Narrative medicine: feasibility of a digital narrative diary application in oncology
Maria Cecilia Cercato, Elvira Colella, Alessandra Fabi, et al.
Breast Cancer Research and Treatment
|
August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
Breast (Edinburgh, Scotland)
|
April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus
Carmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.
Expert Opinion on Pharmacotherapy
|
March 12, 2013
Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer
Alessandra Fabi, Roberta Merola, Gianluigi Ferretti, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
BMC Cancer
|
March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
Current Oncology Reports
|
February 24, 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
Alessandra Fabi, Alessandro Rossi, Edoardo Mocini, et al.
Future Oncology (London, England)
|
May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial
Alessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.
Journal of Personalized Medicine
|
August 27, 2021
Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
Alessia Romito, Sonia Bove, Ilaria Romito, et al.
Cancer Treatment Reviews
|
August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 265) with videos related to
Sort By:
Page
of 27
The Journal of International Medical Research
|
February 2, 2022
Narrative medicine: feasibility of a digital narrative diary application in oncology
Maria Cecilia Cercato, Elvira Colella, Alessandra Fabi, et al.
Breast Cancer Research and Treatment
|
August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
Breast (Edinburgh, Scotland)
|
April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus
Carmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.
Expert Opinion on Pharmacotherapy
|
March 12, 2013
Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer
Alessandra Fabi, Roberta Merola, Gianluigi Ferretti, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
BMC Cancer
|
March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
Current Oncology Reports
|
February 24, 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
Alessandra Fabi, Alessandro Rossi, Edoardo Mocini, et al.
Future Oncology (London, England)
|
May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial
Alessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.
Journal of Personalized Medicine
|
August 27, 2021
Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
Alessia Romito, Sonia Bove, Ilaria Romito, et al.
Cancer Treatment Reviews
|
August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
Page
of 27